Shenzhen Jymed Technology Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is LIRAGLUTIDE, with a corresponding US DMF Number 34171.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 07, 2020, and payment made on September 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II